Given Imaging, which develops capsule endoscopy technology, posted its third quarter results on Tuesday night, reporting revenue and net profit gains against the backdrop of acquisition negotiations with Japanese Fuji.
Net profits for the quarter were $7.9 million as compared with $5.3 million for the same period last year; revenues amounted to $45.4 million for the quarter as compared with $44.7 million for the third quarter of 2011.
The company sold 58,200 PillCam SB capsules in the third quarter, as compared with 58,900 in the third quarter of 2011. It sold 35,000 capsules in the United States as compared with 34,800 in the same quarter last year.
In addition, Given Imaging repeated its 2012 forecast and projects $180-$200 million in earnings with a 70-80 cent profit per share.
Several days ago, Given Imaging announced it was considering an acquisition offer. Calcalist reported that the leading candidate for the acquisition was Japanese Fuji.
The deal reflects a $750 million value for Given, which is a 34% premium over the company's value on NASDAQ.
This report was originally published in Hebrew